Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon

Genetic variability and drug resistance mutations in HIV-1 infected individuals on HAART or drug naïve in Limbe, Cameroon

Bibliographic Details
Main Authors:	Agyingi L, Barengolts D, Mayr L, Kinge T, MBida M, Nyambi P
Format:	Article
Language:	English
Published:	BMC 2012-09-01
Series:	Retrovirology

Similar Items

Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
by: Christian Akem Dimala, et al.
Published: (2016-01-01)

A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
by: Christian Akem Dimala, et al.
Published: (2016-01-01)

The Evolution of HIV-1 Diversity in Rural Cameroon and its Implications in Vaccine Design and Trials
by: Phillipe Nyambi, et al.
Published: (2010-02-01)

Functional changes of the vasculature in HIV/AIDS patients on Haart and Haart Naïve HIV participants
by: Awotedu, Kofoworola Olajire
Published: (2013)

Drug-Resistant HIV-1 RT Gene Mutations in Patients under Treatment with Antiretroviral Drugs (HAART) in Iran
by: Gol Mohammadi, R, et al.
Published: (2015-04-01)

Prevalence of HIV-1 drug resistance mutations in antiretroviral naïve pregnant women from Cambodia, Cameroon, Central African Republic and Vietnam
by: Fleury Hervé, et al.
Published: (2008-04-01)

Pharmacokinetic Considerations for Selection of HAART in Treatment-Naive HIV-Infected Individuals, 2008: More Than it Seems?
by: Andrew D. Luber PharmD
Published: (2008-03-01)

Longitudinal study of primary HIV-1 isolates in drug-naïve individuals reveals the emergence of variants sensitive to anti-HIV-1 monoclonal antibodies.
by: Bijayesh Haldar, et al.
Published: (2011-02-01)

Replication and drug resistant mutation of HIV-1 subtype B' (Thailand B) variants isolated from HAART treatment individuals in China
by: Yuan Lin, et al.
Published: (2009-11-01)

Drug- Resistance- Associated Mutations and HIV Sub-Type Determination in Drug-Naïve and HIV-Positive Patients under Treatment with Antiretroviral Drugs
by: H Naziri, et al.
Published: (2013-10-01)

HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.
by: Farah Bokharaei-Salim, et al.
Published: (2020-01-01)

P04-02. Increased breadth and potency of the neutralizing antibody response among dually-HIV-1-infected individuals
by: Nyambi P, et al.
Published: (2009-10-01)

Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.
by: Lealem Gedefaw, et al.
Published: (2013-01-01)

The Emergence of HIV-1 Transmitted Drug Resistance Mutations Among Antiretroviral Therapy-naive Individuals in Buleleng, Bali, Indonesia
by: Ni Luh Ayu Megasari, et al.
Published: (2019-11-01)

Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected Individuals.
by: Juan Blanco-Heredia, et al.
Published: (2016-01-01)

Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART
by: Daniel Mark, et al.
Published: (2006-05-01)

Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs
by: Elia Paola, et al.
Published: (2009-07-01)

Transmitted Drug Resistance Mutations in Antiretroviral-Naïve Injection Drug Users with Chronic HIV-1 Infection in Iran.
by: Arash Memarnejadian, et al.
Published: (2015-01-01)

Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon
by: Nyambi Phillipe, et al.
Published: (2011-04-01)

HIV Drug Resistance-Associated Mutations in Antiretroviral Naïve HIV-1-Infected Latin American Children
by: Luis E. Soto-Ramirez, et al.
Published: (2010-01-01)

Correction: Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected Individuals.
by: Juan Blanco-Heredia, et al.
Published: (2016-01-01)

Lipid peroxidation and total cholesterol in HAART-naïve patients infected with circulating recombinant forms of human immunodeficiency virus type-1 in Cameroon.
by: Georges Teto, et al.
Published: (2013-01-01)

Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India
by: S. Sinha, et al.
Published: (2012-01-01)

Transmitted drug resistance among HIV-1 drug-naïve patients in Greece
by: Maria Kantzanou, et al.
Published: (2021-04-01)

Effects of medical male circumcision (MC) on plasma HIV viral load in HIV+ HAART naïve men; Rakai, Uganda.
by: Godfrey Kigozi, et al.
Published: (2014-01-01)

HIV drug resistance among naïve HIV-infected patients in Iran
by: Molood Farrokhi, et al.
Published: (2019-01-01)

Hospitalization due to Adverse Drug Reactions and Drug Interactions before and after HAART
by: Michelle M Foisy, et al.
Published: (2000-01-01)

Genetic Markers Associated to Dyslipidemia in HIV-Infected Individuals on HAART
by: Rosmeri K. Lazzaretti, et al.
Published: (2013-01-01)

Update on the Prevalence of Antiretroviral Drug Resistance in Treatment-Naive Individuals
by: Christopher W. James PharmD, et al.
Published: (2013-05-01)

Abacavir-reactive memory T cells are present in drug naïve individuals.
by: Andrew Lucas, et al.
Published: (2015-01-01)

Hair cortisol in drug-naïve first-episode individuals with psychosis
by: Elvis H. Andrade, et al.
Published: (2016-03-01)

Programmatic and Individual-level Factors Associated with CD4 Cell Count at HAART Initiation and Survival Among Treatment-naïve Patients Initiating HAART in sub-Saharan Africa.
by: Eduardo, Eduard
Published: (2014)

Drug Resistance Mutations in Naive HIV-1 South African Patients, and Construction of Molecular Clones to Phenotype Putative Resistance Mutations
by: Mavhandu, Lufuno Grace
Published: (2009)

HIV Drug Resistance in Antiretroviral Treatment-Naïve Individuals in the Largest Public Hospital in Nicaragua, 2011-2015.
by: Santiago Avila-Ríos, et al.
Published: (2016-01-01)

Factors impacting early mortality in tuberculosis/HIV patients: differences between subjects naïve to and previously started on HAART.
by: Carolina Arana Stanis Schmaltz, et al.
Published: (2012-01-01)

Prevalence and detection of drug resistant mutations in Mycobacterium tuberculosis among drug naïve patients in Nairobi, Kenya
by: Collins Otieno Ogari, et al.
Published: (2019-03-01)

Identification of Germinal Center B Cells in Blood from HIV-infected Drug-naive Individuals in Central Africa
by: Lydie Béniguel, et al.
Published: (2004-01-01)

Renal Function Impairment and Associated Factors among HAART Naïve and Experienced Adult HIV Positive Individuals in Southwest Ethiopia: A Comparative Cross Sectional Study.
by: Yewulsew Mekuria, et al.
Published: (2016-01-01)

The KAART Trial: a randomized controlled trial of HAART compared to the combination of HAART and chemotherapy in treatment-naïve patients with HIV-associated Kaposi sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa
by: Aboobaker J, et al.
Published: (2010-10-01)

Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy.
by: Jeffrey A Johnson, et al.
Published: (2008-07-01)